Cellebrite DI (CLBT) Asset Writedowns and Impairment (2024 - 2025)

Cellebrite DI's Asset Writedowns and Impairment history runs 2 years deep, the most recent figure standing at -$2.9 million for Q4 2025.

• On a quarterly basis, Asset Writedowns and Impairment fell 297.86% year-over-year to -$2.9 million in Q4 2025; TTM through Dec 2025 was $554000.0, a 89.62% decrease from a year earlier, with the FY2025 full-year figure at $554000.0, changed N/A from the prior year.
• Asset Writedowns and Impairment eased to -$2.9 million in Q4 2025 per CLBT's latest filing, from $1.2 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $1.4 million in Q4 2024 and bottomed at -$2.9 million in Q4 2025.